Outlook Therapeutics (OTLK) has provided an announcement.
Outlook Therapeutics, Inc. has incentivized its top executives with stock options under its 2015 Equity Incentive Plan, granting varying amounts to the CEO, CFO, Chief Commercial Officer, and a Senior Advisor. These options are split evenly between time-based, which vest over a four-year period, and performance-based, contingent on the company hitting certain milestones. Vesting is conditional upon the executives’ continued employment, aligning their interests with the company’s long-term success.
For detailed information about OTLK stock, go to TipRanks’ Stock Analysis page.
